Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | VP Global Manufacturing | March 03, 2025 | March 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date March 03, 2025 · Filed March 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $58.33 · Expires 2035-03-03 | Direct | 26,127 |
Reported balance
After 2025-03-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-03-03 · Grant · Acquired 26,127 · Balance 26,127 F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2025 Filed Mar 5, 2025 21:11 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 26,127 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008298 · form4.xml · derivative · entry 1 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,127 Underlying: Common Stock · 26,127 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 19:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021576 · form4.xml · derivative · entry 3 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 500 shares Expires 2033-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 19:20 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 122 | $65.34 | $7,971.48 |
DisclosureSEC source: 0001127602-24-021576 · form4.xml · nonDerivative · entry 2 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378 Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 19:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021576 · form4.xml · nonDerivative · entry 1 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:07 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 18,988 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008506 · form4.xml · derivative · entry 1 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,988 Underlying: Common Stock · 18,988 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.